Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria
- PMID: 11379872
- DOI: 10.1007/s004390100477
Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria
Abstract
A 60-year-old Japanese man was diagnosed as having hypouricemia at an annual health check-up. The routine laboratory data was not remarkable except that the patient's hypouricemia and plasma levels of xanthine and hypoxanthine were much higher than those of normal subjects. Furthermore, the patient's daily urinary excretion of xanthine and hypoxanthine was markedly increased compared with reference values. The xanthine dehyrogenase activity of the duodenal mucosa was below the limits of detection. Nevertheless, allopurinol was metabolized to oxypurinol in vivo. Based on these findings, a subtype of classical xanthinuria (type I) was diagnosed. The xanthine dehyrogenase protein was detected by Western blotting analysis. Sequencing of the cDNA of the xanthine dehyrogenase obtained from the duodenal mucosa revealed that a point mutation of C to T had occurred in nucleotide 445. This changed codon 149 from CGC (Arg) to TGC (Cys), a finding that has not been previously reported in patients with classical xanthinuria type I.
Similar articles
-
Identification of a new point mutation in the human molybdenum cofactor sulferase gene that is responsible for xanthinuria type II.Metabolism. 2003 Nov;52(11):1501-4. doi: 10.1016/s0026-0495(03)00272-5. Metabolism. 2003. PMID: 14624414
-
Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria.J Clin Invest. 1997 May 15;99(10):2391-7. doi: 10.1172/JCI119421. J Clin Invest. 1997. PMID: 9153281 Free PMC article.
-
Two siblings with classical xanthinuria type 1: significance of allopurinol loading test.Intern Med. 1998 Jan;37(1):77-82. doi: 10.2169/internalmedicine.37.77. Intern Med. 1998. PMID: 9510406
-
Mutations associated with functional disorder of xanthine oxidoreductase and hereditary xanthinuria in humans.Int J Mol Sci. 2012 Nov 21;13(11):15475-95. doi: 10.3390/ijms131115475. Int J Mol Sci. 2012. PMID: 23203137 Free PMC article. Review.
-
[Classical xanthinuria (type I and II)].Ryoikibetsu Shokogun Shirizu. 1998;(18 Pt 1):470-3. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9590104 Review. Japanese. No abstract available.
Cited by
-
Xanthinuria in a familial group of Munchkin cats and an unrelated domestic shorthair cat.J Feline Med Surg. 2024 May;26(5):1098612X241241408. doi: 10.1177/1098612X241241408. J Feline Med Surg. 2024. PMID: 38717789 Free PMC article.
-
Computational Characterization of the Inhibition Mechanism of Xanthine Oxidoreductase by Topiroxostat.ACS Catal. 2023 May 5;13(9):6023-6043. doi: 10.1021/acscatal.3c01245. Epub 2023 Apr 18. ACS Catal. 2023. PMID: 37547543 Free PMC article.
-
Association of Mutations Identified in Xanthinuria with the Function and Inhibition Mechanism of Xanthine Oxidoreductase.Biomedicines. 2021 Nov 20;9(11):1723. doi: 10.3390/biomedicines9111723. Biomedicines. 2021. PMID: 34829959 Free PMC article. Review.
-
An ancestral variant causing type I xanthinuria in Turkmen and Arab families is predicted to prevail in the Afro-Asian stone-forming belt.JIMD Rep. 2019 Dec 5;51(1):45-52. doi: 10.1002/jmd2.12077. eCollection 2020 Jan. JIMD Rep. 2019. PMID: 32071838 Free PMC article.
-
Physiology of Hyperuricemia and Urate-Lowering Treatments.Front Med (Lausanne). 2018 May 31;5:160. doi: 10.3389/fmed.2018.00160. eCollection 2018. Front Med (Lausanne). 2018. PMID: 29904633 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
